QI
ACHV icon

QS Investors’s Achieve Life Sciences ACHV Stock Holding History

QS Investors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$306K Buy
+34,050
New +$324K ﹤0.01% 937

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

QS Investors's ACHV Position: Q2 2021 in Review

QS Investors opened a new position in Achieve Life Sciences (ACHV) in Q2 2021: 34,050 shares worth $306K. The stake represents ﹤0.01% of the portfolio and ranks #937 among its holdings.

29 funds tracked by Wall St. Rank hold ACHV as of Q2 2021.

  • QS Investors held 34,050 shares of Achieve Life Sciences worth $306K as of Q2 2021.
  • Achieve Life Sciences was a new QS Investors position in Q2 2021.
  • Achieve Life Sciences made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #937 holding.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.